Cannabis Bioscience International Holdings, Inc.
CBIH
$0.00
$0.0025.00%
OTC PK
| 05/31/2025 | 02/28/2025 | 11/30/2024 | 08/31/2024 | 05/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -53.89% | -59.07% | 16.48% | 145.74% | 63.58% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -53.89% | -59.07% | 16.48% | 145.74% | 63.58% |
| Cost of Revenue | -54.55% | 64.41% | -48.34% | -4.55% | -38.13% |
| Gross Profit | -53.94% | -118.29% | 36.34% | 166.41% | 117.11% |
| SG&A Expenses | 60.46% | -25.62% | -11.94% | 11.34% | -68.69% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 49.67% | -20.21% | -15.41% | 10.78% | -67.16% |
| Operating Income | -315.54% | 11.38% | 36.93% | 44.80% | 89.23% |
| Income Before Tax | -55.78% | 8.03% | 36.09% | 58.03% | 50.76% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -55.78% | 8.03% | 36.09% | 58.03% | 50.76% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -55.78% | 8.03% | 36.09% | 58.03% | 50.76% |
| EBIT | -315.54% | 11.38% | 36.93% | 44.80% | 89.23% |
| EBITDA | -- | -- | -- | -- | -- |
| EPS Basic | -- | -- | -- | -- | -- |
| Normalized Basic EPS | -- | -- | -- | -- | -- |
| EPS Diluted | -- | -- | -- | -- | -- |
| Normalized Diluted EPS | -- | -- | -- | -- | -- |
| Average Basic Shares Outstanding | 8.01% | 3.41% | 1.60% | 1.23% | 4.94% |
| Average Diluted Shares Outstanding | 8.01% | 3.41% | 1.60% | 1.23% | 4.94% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |